Luca Rinaldi

7.8k total citations · 6 hit papers
155 papers, 4.5k citations indexed

About

Luca Rinaldi is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Luca Rinaldi has authored 155 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 46 papers in Hepatology and 38 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Luca Rinaldi's work include Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (30 papers) and Diabetes Treatment and Management (19 papers). Luca Rinaldi is often cited by papers focused on Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (30 papers) and Diabetes Treatment and Management (19 papers). Luca Rinaldi collaborates with scholars based in Italy, United States and United Kingdom. Luca Rinaldi's co-authors include Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Raffaele Marfella, Pia Clara Pafundi, Riccardo Nevola, Erica Vetrano and Aldo Marrone and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Luca Rinaldi

145 papers receiving 4.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

2023 270 citations Alfredo Caturano, Vincenzo Russo et al. profile →
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives

2023 161 citations Riccardo Nevola, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

2022 152 citations Teresa Salvatore, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
Predictors of early and late hepatocellular carcinoma recurrence

2023 102 citations Riccardo Nevola, Domenico Cozzolino et al. profile →
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options

2023 89 citations Raffaele Galiero, Alfredo Caturano et al. International Journal of Molecular Sciences profile →
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications

2025 40 citations Alfredo Caturano, Maria Rocco et al. Antioxidants profile →

Peers

Countries citing papers authored by Luca Rinaldi

Since Specialization

Citations

This map shows the geographic impact of Luca Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Rinaldi more than expected).

Fields of papers citing papers by Luca Rinaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Rinaldi. The network helps show where Luca Rinaldi may publish in the future.

Co-authorship network of co-authors of Luca Rinaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Rinaldi. A scholar is included among the top collaborators of Luca Rinaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Rinaldi. Luca Rinaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad 2025 ·European Journal of Clinical Investigation ·Alfredo Caturano, Enes Erul, (unknown), (unknown), Vincenzo Russo, Luca Rinaldi, Carlo Acierno, Erman Akkuş, (unknown), Federica Cerini, (unknown), Ferdinando Carlo Sasso, Leonilde Bonfrate, Antonio Giordano, (unknown), Caterina Conte	0
2	Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm 2025 ·Reviews in Cardiovascular Medicine ·Alfredo Caturano, (unknown), Giovanni Di Lorenzo, Maria Rocco, (unknown), (unknown), (unknown), (unknown), S. Moretto, Carlo Acierno, Celestino Sardu, Vincenzo Russo, Marco Alfonso Perrone, Erica Vetrano, Raffaele Galiero, Raffaele Marfella, Leonilde Bonfrate, Luca Rinaldi, Caterina Conte, Ferdinando Carlo Sasso	0
3	Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications breakdown → 2025 ·Antioxidants ·Alfredo Caturano, Maria Rocco, (unknown), (unknown), (unknown), Giovanni Di Lorenzo, (unknown), (unknown), Raffaele Galiero, Carlo Acierno, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Caterina Conte, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso	40
4	Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 2025 ·Exploration of Medicine ·Luigi Elio Adinolfi, Aldo Marrone, Luca Rinaldi, Riccardo Nevola, Antonio Izzi, Ferdinando Carlo Sasso	5
5	Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 2025 ·Pharmaceuticals ·Erica Vetrano, Raffaele Galiero, Vittorio Simeon, Giuseppe Palmiero, Arturo Cesaro, Alfredo Caturano, Luca Rinaldi, Teresa Salvatore, Roberto Ruggiero, (unknown), Celestino Sardu, Raffaele Marfella, Paolo Calabrò, Ferdinando Carlo Sasso	0
6	On humans' (explicit) intuitions about the meaning of novel words 2024 ·Cognition ·Daniele Gatti, (unknown), Luca Rinaldi, Marco Marelli	0
7	Advances in Nanomedicine for Precision Insulin Delivery 2024 ·Pharmaceuticals ·Alfredo Caturano, (unknown), (unknown), Vincenzo Russo, (unknown), Raffaele Galiero, Luca Rinaldi, Marcellino Monda, Celestino Sardu, Raffaele Marfella, Ferdinando Carlo Sasso	16
8	Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 2024 ·International Journal of Molecular Sciences ·Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso	19
9	The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 2024 ·Biomolecules ·Alfredo Caturano, Raffaele Galiero, Maria Rocco, (unknown), (unknown), (unknown), Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso	6
10	Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 2024 ·International Journal of Molecular Sciences ·Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso	7
11	Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 2024 ·SHILAP Revista de lepidopterología ·Alfredo Caturano, (unknown), (unknown), Gaetano Vaudo, Vincenzo Russo, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Marcellino Monda, Giovanni Luca, Ferdinando Carlo Sasso	4
12	Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 2023 ·Journal of Clinical Medicine ·Domenico Cozzolino, Ciro Romano, Celestino Sardu, Riccardo Nevola, Giuseppina Rosaria Umano, Luca Rinaldi, Luigi Elio Adinolfi, (unknown), Aldo Marrone, Maurizio Municinò, Ferdinando Carlo Sasso, Raffaele Marfella	1
13	Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 2023 ·Biomedicines ·Alfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, Erica Vetrano, (unknown), Carlo Acierno, Luca Rinaldi, Aldo Marrone, Teresa Salvatore, Marcellino Monda, Celestino Sardu, Raffaele Marfella, Ferdinando Carlo Sasso	30
14	Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 2022 ·Applied Surface Science Advances ·(unknown), Federica Dell’Annunziata, Rosa Giugliano, Annalisa Chianese, Anna De Filippis, Luca Rinaldi, U. Gambardella, Gianluigi Franci, Massimiliano Galdiero, A. Morone	17
15	The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies 2022 ·Antioxidants ·Massimiliano Berretta, Vincenzo Quagliariello, Alessia Bignucolo, Sergio Facchini, Nicola Maurea, Raffaele Di Francia, Francesco Fiorica, (unknown), Silvia Bressan, Sara N. Richter, Valentina Camozzi, Luca Rinaldi, Carla Scaroni, Monica Montopoli	22
16	Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 2021 ·International Journal of Molecular Sciences ·Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Elisabetta Moscarella, Felice Gragnano, Teresa Salvatore, Luca Rinaldi, Paolo Calabrò, Ferdinando Carlo Sasso	71
17	Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 2021 ·Diagnostics ·Pia Clara Pafundi, Carlo Garofalo, Raffaele Galiero, Silvio Borrelli, Alfredo Caturano, Luca Rinaldi, Michele Provenzano, Teresa Salvatore, Luca De Nicola, Roberto Minutolo, Ferdinando Carlo Sasso	23
18	Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies 2020 ·Antioxidants ·Massimiliano Berretta, Vincenzo Quagliariello, Nicola Maurea, Raffaele Di Francia, (unknown), Gaetano Facchini, Luca Rinaldi, Michela Piezzo, (unknown), Giuseppe Nunnari, Monica Montopoli	66
19	Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents. 2020 ·PubMed ·(unknown), Vincenzo Messina, Luca Rinaldi, Paolo Maggi	13
20	No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis. 2018 ·PubMed ·Rosa Zampino, Margherita Macera, Grazia Cirillo, Pia Clara Pafundi, Luca Rinaldi, Nicola Coppola, Mariantonietta Pisaturo, Luigi Elio Adinolfi, Emanuele Miraglia del Giudice, Diego Ingrosso, Rosanna Capasso	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact